Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marina Nguenang
Observed names:
M Nguenang,
M. Nguenang,
Nguenang, Marina
Institution:
Centre Hospitalier de Luxembourg
Observed institutions:
Inserm,
Centre Hospitalier de Luxembourg,
Université Paris Cité,
Assistance Publique – Hôpitaux de Paris,
Hôpital Bichat-Claude-Bernard,
Centre Hospitalier Saint-Denis,
Université Paris Diderot,
Centre d'Investigation Clinique Bichat
show all 8
OpenAlex ID:
A5044041865
Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer
2019
·
Sandra Assoun
, Nathalie Theou-Anton
, et al.
·
Lung Cancer
·
176
PDF
Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer
2018
·
Adrien Costantini
, Jennifer Corny
, et al.
·
ERJ Open Research
·
26
PDF
Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors
2020
·
Clémentine Bouchez
, Johan Pluvy
, et al.
·
BMC Cancer
·
14
PDF
A newKIF5B–ERBB4gene fusion in a lung adenocarcinoma patient
2021
·
Edouard Guenzi
, Johan Pluvy
, et al.
·
ERJ Open Research
·
9
PDF
Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report
2019
·
Johan Pluvy
, Solenn Brosseau
, et al.
·
BMC Pulmonary Medicine
·
8
PDF
Traitements péri-opératoires des carcinomes bronchiques non à petites cellules
2017
·
S. Brosseau
, C. Naltet
, et al.
·
Revue des Maladies Respiratoires
·
8
RET-Rearranged Lung Adenocarcinoma with Paraneoplastic Meige Syndrome
2019
·
Baptiste Abbar
, Carole Henry
, et al.
·
Journal of Thoracic Oncology
·
2
PDF
Nódulo pulmonar aislado
2019
·
S. Brosseau
, M. Nguenang
, et al.
·
EMC - Tratado de Medicina
·
1
TP53 mutations as predictor of response and longer survival under immune checkpoint inhibitors in advanced non-small cell lung cancer
2018
·
S. Assoun
, N. Theou-Anton
, et al.
·
Annals of Oncology
·
1
Shrinking lung syndrome with favourable response to belimumab and corticosteroids alone
2026
·
Rémy Père
, Anouk Le Goueff
, et al.
·
European Journal of Case Reports in Internal Medicine
PDF
PO-1011: Impact of radiation therapy on immunotherapy efficacy in metastatic non-small cell lung cancer.
2020
·
M. Darrason
, E. Rivin del Campo
, et al.
·
Radiotherapy and Oncology
Impact de la radiothérapie (RT) sur l’efficacité de l’immunothérapie : étude rétrospective dans les carcinomes bronchiques non à petites cellules (CBNPC) métastatiques
2020
·
M. Darrason
, E. Rivin Del Campo
, et al.
·
Revue des Maladies Respiratoires Actualités
Iconografías adicionales del artículo : Nódulo pulmonar aislado
2019
·
S Brosseau
, M Nguenang
, et al.
Nodulo polmonare solitario
2019
·
S. Brosseau
, M. Nguenang
, et al.
·
EMC - AKOS - Trattato di Medicina
Comment optimiser le diagnostic histo-pathologique du cancer du poumon ?
2018
·
V. Gounant
, J. Pluvy
, et al.
·
Revue des Maladies Respiratoires Actualités
Hyper-progressive disease in patients with advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo)
2018
·
Adrien Costantini
, Jennifer Corny
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
19
Citation count:
245
H-index:
6
I10-index:
3
Year
Topic
Type